Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Stickel

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Archives of Internal Medicine|September 15, 2005
Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosisFelix Stickel, Christoph H Osterreicher, Christian Datz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 13, 2014
K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cellsChristian Freise, Silke Heldwein, Ulrike Erben, et al.
Journal of Personalized Medicine|May 28, 2022
Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related MortalitySarah Wernly, Georg Semmler, Andreas Völkerer, et al.
The Journal of Nutritional Biochemistry|October 1, 2008
Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression patternMartin Ruehl, Ulrike Erben, Kiyoung Kim, et al.
Molecular Medicine (Cambridge, Mass.)|August 25, 2011
Cannabinoid receptor type I modulates alcohol-induced liver fibrosisEleonora Patsenker, Matthias Stoll, Gunda Millonig, et al.
The American Journal of Gastroenterology|April 22, 2010
A role for low hepatic copper concentrations in nonalcoholic Fatty liver diseaseElmar Aigner, Michael Strasser, Heike Haufe, et al.
The Journal of Nutritional Biochemistry|June 12, 2022
The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fatsEleonora Patsenker, Veera Raghavan Thangapandi, Oskar Knittelfelder, et al.
Journal of Personalized Medicine|April 3, 2021
PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary CenterGeorg Semmler, Lorenz Balcar, Hannes Oberkofler, et al.
World Journal of Gastroenterology|February 25, 2010
Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitisSebastian Mueller, Gunda Millonig, Lucie Sarovska, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2021
PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary centerLorenz Balcar, Georg Semmler, Hannes Oberkofler, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Archives of Internal Medicine|September 15, 2005
Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosisFelix Stickel, Christoph H Osterreicher, Christian Datz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 13, 2014
K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cellsChristian Freise, Silke Heldwein, Ulrike Erben, et al.
Journal of Personalized Medicine|May 28, 2022
Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related MortalitySarah Wernly, Georg Semmler, Andreas Völkerer, et al.
The Journal of Nutritional Biochemistry|October 1, 2008
Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression patternMartin Ruehl, Ulrike Erben, Kiyoung Kim, et al.
Molecular Medicine (Cambridge, Mass.)|August 25, 2011
Cannabinoid receptor type I modulates alcohol-induced liver fibrosisEleonora Patsenker, Matthias Stoll, Gunda Millonig, et al.
The American Journal of Gastroenterology|April 22, 2010
A role for low hepatic copper concentrations in nonalcoholic Fatty liver diseaseElmar Aigner, Michael Strasser, Heike Haufe, et al.
The Journal of Nutritional Biochemistry|June 12, 2022
The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fatsEleonora Patsenker, Veera Raghavan Thangapandi, Oskar Knittelfelder, et al.
Journal of Personalized Medicine|April 3, 2021
PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary CenterGeorg Semmler, Lorenz Balcar, Hannes Oberkofler, et al.
World Journal of Gastroenterology|February 25, 2010
Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitisSebastian Mueller, Gunda Millonig, Lucie Sarovska, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2021
PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary centerLorenz Balcar, Georg Semmler, Hannes Oberkofler, et al.
Pageof 17